期刊文献+

人乳头瘤病毒和核因子κB与卵巢癌关系的研究进展

Research Advancement of HPV and NF-κB Expression in Epithelial Ovarian Carcinoma
下载PDF
导出
摘要 高危型人乳头瘤病毒感染与多种上皮性恶性肿瘤的发生有关。它与卵巢癌的关系也已受到关注。人乳头瘤病毒致癌是一个多因素、多步骤的渐进过程,其中协同因素也发挥重要作用。核因子κB在连接慢性炎症和肿瘤的过程中发挥重要的作用,卵巢癌组织中核因子κB有很高的阳性表达。现对人乳头瘤病毒、核因子κB在卵巢癌中的研究进展予以综述。 Infection of high-risk human papillomaviruses can lead to the development of many epithelial cell carcinomas and its role in ovarian cancer has drawn more attention.The carcinogenesis of HPV is a multi-factor and multi-step process,in which genetic and synergistic factors also play an important role.NF-κB plays an important role in inflammation-associated cancer.The high expression of NF-κB has been found in epithelial ovarian carcinoma.This article reviews HPV and NF-κB in terms of the progress in the mechanism of epithelial ovarian carcinoma.
作者 金友存 孔祥
出处 《医学综述》 2010年第17期2637-2639,共3页 Medical Recapitulate
关键词 人乳头瘤病毒 核因子КB 卵巢癌 Human papillomavirus Nuclear transcription factor-κB Epithelial ovarian carcinoma
  • 相关文献

参考文献19

  • 1Dunne EF,Markowitz LE.Genital human papillomavirus infection[J].Clin Infect Dis,2006,43 (5):624-629.
  • 2Steben M,Duarte-Franco E.Human Papillomavirus infection:Epidemiology and pathophysiology[J].Gynecol Oncol,2007,107 (2Suppl 1):2-5.
  • 3Beatty GL,Vonderheide BH.Telomerase as a universal tumor antigen for cancer vaccines[J].Expert Rev Vaccines,2008,7(7):881-887.
  • 4Gewin L,Myers H,Kiyono T.Identification of a novel telomerase repressor that interacts with the human papillomavirus type-16 E6/E6-AP complex[J].Genes Dev,2004,18 (18):2269-2282.
  • 5Veldman T,Liu X,Yuan H,et al.Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activte the telomerase reverse t ranscriptase promoter[J].Proc Natl Acad Sci USA,2003,100(14):8211-8216.
  • 6Boulet G,Horvath DV.Human papillomavirus:E6 and E7 oncogenes[J].Int J Biochem Cell Biol,2007,39 (11):2006-2011.
  • 7Liu X,Clements A,Zhao KH,et al.Structure of the human papillomavirus E7oacoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor[J].Biol Chem,2006,281 (1):578-586.
  • 8Lee SH,Kin JW,Lee HW,et al.Interferon regulatory factor-1(IRF-1) is a mediator for interferon-gamma induced attenuation of telomerase activity and human telomerase reverse transcrip tase (hTERT) expression[J].Oncogene,2003,22 (3):381-391.
  • 9Kuscu E,Ozdemir BH,Erkanli S,et al.HPV and p53 expression in epithelial ovarian carcinoma[J].Eur J Gynae Oncol,2005,26(6):642-645.
  • 10Atalay F,Taskiran C,Taner MZ,et al.Detection of human papillomavirus DNA and genotyping in patients with epithelial ovarian carcinoma[J].Obstet Gynaccol Res,2007,33(6):823-828.

二级参考文献27

  • 1罗敏捷.人乳头状瘤病毒致癌机制[J].国外医学(生理病理科学与临床分册),1996,16(3):147-150. 被引量:2
  • 2王言奎,罗兵,王云,纪祥瑞,戴淑真.人乳头瘤病毒感染与上皮性卵巢癌关系的初步探讨[J].青岛医学院学报,1997,33(1):19-21. 被引量:1
  • 3Howley PM. Role of the human papillomavirus in human cancer[J]. Cancer Res,1991,51:5019.
  • 4Mai KT, Yazdi HM, Bertrand MA, et al. Bilateral primary ovarian squamous call carcinoma associated with human papilloma virus infection and vulvar and cervical intraepithelial neoplasia[ J ]. Am J Surg Pathol, 1996,20:767.
  • 5Lai CH, Wang CY, Lin CY, et al. Detection of human papillomavirus RNA in ovarian and endometrial carcinomas by reverse transcription polymcrase chain reaction [ J ]. Gynecol Obstet Invest,1994,38 (4) : 276.
  • 6Karen TS. Making a valid point about HPV tests[J]. Cap Today,2005,9 : 166.
  • 7Duffy M J.Evidence for the clinical use of tumor marker[J].Gynecol Oncol,2004,94(1):74-79.
  • 8Liu J,Yang G,Thompson-Lanza J A,etal.A genetically defined model for human ovarian cancer[J].Cancer Res,2004,64(5):1655 -1663.
  • 9Salvatore C,Camarda G,Maggi C A,et al.NF-kappaB activation contributes to anthracycline resistance pathway in human ovarian carcinoma cell line A2780[J].Int J Oncol,2005,27(3):799-806.
  • 10Preethi T R,Chacko P,Kesari A L.Apoptosis in epithelial ovarian tumors[J].Pathol Res Pract,2002,198:273-279.

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部